These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2877194)

  • 21. [Sequencing of adjuvant treatment after surgery for invasive breast cancer].
    Petit T; Claude L; Carrie C
    Cancer Radiother; 2004 Feb; 8(1):54-8. PubMed ID: 15093202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a role for perioperative adjuvant therapy in the treatment of early breast cancer?
    Houghton J; Baum M; Nissen-Meyer R
    Eur J Surg Oncol; 1988 Jun; 14(3):227-33. PubMed ID: 3286285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant chemotherapy in breast cancer.
    Bonadonna G; Rossi A; Tancini G; Valagussa P
    Lancet; 1983 May; 1(8334):1157. PubMed ID: 6133169
    [No Abstract]   [Full Text] [Related]  

  • 24. Adjuvant chemotherapy in early breast cancer.
    Raemaekers JM; Beex LV; Smals AG; Benraad TJ; Kloppenborg PW
    Lancet; 1986 Oct; 2(8511):861. PubMed ID: 2876301
    [No Abstract]   [Full Text] [Related]  

  • 25. [Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both].
    Clavel B; Cappelaere JP; Guerin J; Klein T; Pommatau E; Berlie J
    Sem Hop; 1982 Sep; 58(34):1919-23. PubMed ID: 6293073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant chemotherapy.
    Osborne CK; Coltman CA
    CA Cancer J Clin; 1986; 36(1):59-60. PubMed ID: 3080209
    [No Abstract]   [Full Text] [Related]  

  • 27. Trials of adjuvant chemotherapy in breast cancer. The experience of the Istituto Nazionale Tumori of Milan.
    Rossi A; Bonadonna G; Tancini G; Bajetta E; Marchini S; Valagussa P; Veronesi U
    Eur J Cancer (1965); 1980; Suppl 1():149-56. PubMed ID: 7032924
    [No Abstract]   [Full Text] [Related]  

  • 28. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.
    Jonat W; Kaufmann M; Sauerbrei W; Blamey R; Cuzick J; Namer M; Fogelman I; de Haes JC; de Matteis A; Stewart A; Eiermann W; Szakolczai I; Palmer M; Schumacher M; Geberth M; Lisboa B;
    J Clin Oncol; 2002 Dec; 20(24):4628-35. PubMed ID: 12488406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LHRH analogues in early breast cancer.
    Jonat W
    Horm Res; 1989; 32 Suppl 1():223-5. PubMed ID: 2533156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
    Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
    Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical controlled trial in advanced breast cancer: CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CMF + T (cyclophosphamide, methotrexate, 5-fluorouracil, tamoxifen). CMEA Cooperative Treatment Group.
    Neoplasma; 1985; 32(3):381-7. PubMed ID: 2862594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant chemotherapy in breast cancer: back to the future.
    Colleoni M; Goldhirsch A
    Onkologie; 2003 Apr; 26(2):111-2. PubMed ID: 12771517
    [No Abstract]   [Full Text] [Related]  

  • 34. Using clinical trial information in the practice of medicine.
    Henderson IC
    Cancer J Sci Am; 1995; 1(2):101-3. PubMed ID: 9166459
    [No Abstract]   [Full Text] [Related]  

  • 35. [Radio-chemotherapy integration].
    Boidi Trotti A
    Minerva Ginecol; 1985 Jun; 37(6):281-2. PubMed ID: 3839916
    [No Abstract]   [Full Text] [Related]  

  • 36. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.
    Bellon JR; Come SE; Gelman RS; Henderson IC; Shulman LN; Silver BJ; Harris JR; Recht A
    J Clin Oncol; 2005 Mar; 23(9):1934-40. PubMed ID: 15774786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paradigm shift in adjuvant treatment of receptor positive premenopausal breast cancer patients? Not yet!
    Samur M; Bozcuk HS
    J Clin Oncol; 2003 Jun; 21(12):2444; author reply 2445-7. PubMed ID: 12805349
    [No Abstract]   [Full Text] [Related]  

  • 38. [5 years' results of a CMF protocol (methotrexate, cyclophosphamide, fluorouracil) of adjuvant chemotherapy in breast cancers].
    Horner-Vallet D; Cappelaere P; Delobelle A; Depadt G; Madelain M; Demaille A
    LARC Med; 1984 Nov; 4(9):532-40. PubMed ID: 6549038
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjuvant chemotherapy combined with tamoxifen in postmenopausal patients with stage II breast cancer.
    Zielinski CC; Kubista E; Salzer H; Sevelda P; Langer M; Staffen A; Spona J; Aiginger P
    Lancet; 1986 Nov; 2(8516):1164. PubMed ID: 2877314
    [No Abstract]   [Full Text] [Related]  

  • 40. Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer.
    Hubay CA; Pearson OH; Marshall JS; Rhodes RS; Debanne SM; Mansour EG; Hermann RE; Jones JC; Flynn WJ; Eckert C; McGuire WL
    Eur J Cancer (1965); 1980; Suppl 1():189-95. PubMed ID: 7032932
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.